Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypercoagulable states and venous thrombosis.

D A Haake, S A Berkman

    Hospital Practice (Office Ed.)
    |December 15, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Identifying risk factors for thromboembolic disease is crucial for effective treatment. Prompt diagnosis and appropriate anticoagulation, tailored to individual risk, improve patient outcomes and prevent complications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunohistochemical identification and pathologic findings in natural cases of equine abortion caused by leptospiral infection.

    Veterinary pathology·2006
    Same author

    Genome features of Leptospira interrogans serovar Copenhageni.

    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2004
    Same author

    Comparative genomics of two Leptospira interrogans serovars reveals novel insights into physiology and pathogenesis.

    Journal of bacteriology·2004
    Same author

    [Alignment of DNA sequences of ompL1 genes of insert fragment of recombinant plasmid, pDC38 of L. interrogans serovar lai and L. kirschneri].

    Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao·2002
    Same author

    Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis.

    Journal of clinical microbiology·2001
    Same author

    Leptospiral proteins recognized during the humoral immune response to leptospirosis in humans.

    Infection and immunity·2001

    Area of Science:

    • Vascular Medicine
    • Hematology
    • Surgical Outcomes

    Background:

    • Thromboembolic disease arises from various patient factors, ranging from idiopathic causes in the young to clear hypercoagulability in high-risk individuals.
    • Obesity, immobility, postoperative status, and malignancy significantly increase the risk of thromboembolic events.
    • Accurate diagnosis is essential, as treatment decisions hinge on test results.

    Purpose of the Study:

    • To outline the diagnostic approach to patients at risk for thromboembolic disease.
    • To guide treatment decisions based on diagnostic findings.
    • To discuss the duration and methods of anticoagulation and inferior vena cava interruption.

    Main Methods:

    • Evaluation of patient risk factors for thromboembolic disease.

    Related Experiment Videos

  • Application of invasive and noninvasive testing in suspicious cases.
  • Review of current anticoagulation strategies and prophylactic measures.
  • Comparison of transvenous devices versus surgical techniques for vena cava interruption.
  • Main Results:

    • Prompt treatment for positive diagnostic findings is recommended; anticoagulation is not advised for negative results.
    • Anticoagulation duration is variable, based on ongoing thrombosis risk, from months to lifelong.
    • Prophylactic anticoagulation (e.g., minidose heparin) is advised for patients over 40 undergoing abdominal/thoracic surgery.
    • Hip surgery patients require anticoagulation (heparin, warfarin, aspirin, etc.).

    Conclusions:

    • Diagnostic testing is vital for guiding thromboembolic disease management.
    • Treatment and anticoagulation duration should be individualized based on risk and test results.
    • Transvenous devices offer superior long-term efficacy and lower morbidity for inferior vena cava interruption compared to surgical methods.